Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Westlake

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
International Journal of Clinical Pharmacology and Biopharmacy|June 1, 1975
Statistical problems in interpreting comparative bioavailability trialsW J Westlake
Journal of Pharmaceutical Sciences|June 1, 1975
Letter: Demonstration of claimed "controlled-release" properties of a drug formulationW J Westlake
Journal of Pharmaceutical Sciences|May 1, 1970
Time integral of drug concentration in the central (plasma) compartmentW J Westlake
Journal of Pharmaceutical Sciences|June 1, 1971
Problems associated with analysis of pharmacokinetic modelsW J Westlake
Psychopharmacology Bulletin|October 1, 1976
Statistical implications in generic equivalentsW J Westlake
Journal of Pharmaceutical Sciences|October 1, 1973
Use of statistical methods in evaluation of in vivo performance of dosage formsW J Westlake
Biometrics|June 1, 1974
The use of balanced incomplete block designs in comparative bioavailability trailsW J Westlake
Biometrics|March 1, 1979
Statistical aspects of comparative bioavailability trialsW J Westlake
Biometrics|December 1, 1976
Symmetrical confidence intervals for bioequivalence trialsW J Westlake
Acta Pharmaceutica Suecica|December 1, 1975
Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experimentsW J Westlake
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Pharmacology and Biopharmacy|June 1, 1975
Statistical problems in interpreting comparative bioavailability trialsW J Westlake
Journal of Pharmaceutical Sciences|June 1, 1975
Letter: Demonstration of claimed "controlled-release" properties of a drug formulationW J Westlake
Journal of Pharmaceutical Sciences|May 1, 1970
Time integral of drug concentration in the central (plasma) compartmentW J Westlake
Journal of Pharmaceutical Sciences|June 1, 1971
Problems associated with analysis of pharmacokinetic modelsW J Westlake
Psychopharmacology Bulletin|October 1, 1976
Statistical implications in generic equivalentsW J Westlake
Journal of Pharmaceutical Sciences|October 1, 1973
Use of statistical methods in evaluation of in vivo performance of dosage formsW J Westlake
Biometrics|June 1, 1974
The use of balanced incomplete block designs in comparative bioavailability trailsW J Westlake
Biometrics|March 1, 1979
Statistical aspects of comparative bioavailability trialsW J Westlake
Biometrics|December 1, 1976
Symmetrical confidence intervals for bioequivalence trialsW J Westlake
Acta Pharmaceutica Suecica|December 1, 1975
Proceedings: Statistical considerations in the planning and analysis of pharmacokinetic experimentsW J Westlake
Pageof 2